Online Exclusives

Online Exclusives

Global Patient Registry Launched for Castleman Disease

ACCELERATE (Accelerating Castleman Care with Electronic Longitudinal registry, E-Repository, And Treatment Effectiveness research), a patient-driven natural history registry for patients with Castleman disease, was...

Europe’s CHMP Recommends Rituximab Biosimilar Approval

Europe’s Committee for Medicinal Products for Human Use (CHMP) recommended approval for a biosimilar version of rituximab for the treatment of non-Hodgkin lymphoma (NHL)...

Radon Exposure Linked to Increased Blood Cancer Risk in Women

A study published in Environmental Research found that residential radon exposure – from contaminated soil, groundwater, and surrounding air – may be a risk...

Technology to Grow Blood Vessels Licensed for Development

Researchers at Indiana University have developed technology that creates human blood vessels. This could be a potential treatment option for patients with peripheral arterial...

Psychologic Distress Related to Mortality for Leukemia, Other Cancer Types

Anxiety, depression, and psychologic distress may be linked to cancer mortality, particularly for patients with leukemia, according to a meta-analysis published in BMJ by...

Study Compares Quality of Care Under U.S.- and Foreign-Trained Doctors

An observational study published in BMJ suggests that older patients who were hospitalized and treated by doctors who graduated from non-U.S. medical schools had...

Pediatric Patients With Down Syndrome and ALL Can Be Safely, Effectively Treated With Standard...

Treatment modifications and dose reductions are common strategies in managing pediatric patients with Down syndrome and acute lymphocytic leukemia (ALL). According to results from...

Organ Donations from Patients With Cancer Have Increased in the UK

According to a report from the National Health Service, organ donations from patients with cancer have increased in the United Kingdom (UK) over the...

Europe’s CHMP Recommends Against Approval of Ixazomib for Relapsed/Refractory Myeloma

Europe’s Committee for Medicinal Products for Human Use (CHMP) did not recommend approval for oral ixazomib for patients with relapsed/refractory multiple myeloma (MM), citing...

New Bill to Speed Up Generic Drug Approvals Introduced in Senate

U.S. Senators Susan Collins and Claire McCaskill have introduced the Increasing Competition in Pharmaceuticals Act, a bill to ensure that a clear process is...
Advertisement

Current Issue

December 2019, Volume 5, Issue 15

This issue examines the hidden costs of participating in clinical trials, explores the pediatric hematology/oncology workforce, and more.